BioCentury
ARTICLE | Company News

Johannes Gutenberg University Mainz, ITM Isotopen Technologien Muenchen deal

October 12, 2015 7:00 AM UTC

The university granted Isotopen’s Isotope Technologies Garching GmbH subsidiary exclusive, worldwide rights to commercialize DOTA-Zoledronate, a next-generation theranostic agent for bone-targeted ra...